Total Funding
7
Total FundingDebt Financing raised
Growth Score
pts
Heat Score
-2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
4007159
Neuronex is a development-stage pharmaceutical company that focuses on drugs that treat central nervous system diseases and disorders.
Acquired by 
Acorda Therapeutics
Gary Bream: VP, Scientific AffairsPast Role: Addrenex Pharmaceuticals, Vice President of Scientific Affairs
About the Company
Neuronex is a development stage pharmaceutical company focused on drugs that treat Central Nervous System (CNS) diseases and disorders. The company aims to combine clinical expertise with a thorough knowledge of the drug development process in a nimble, entrepreneurial environment, to achieve rapid success in obtaining approvals for there
products.
